| 英文名稱 | Alisol B 23-acetate |
|---|---|
| 中文名稱 | 澤瀉醇B-23-醋酸酯/澤瀉醇B單醋酸酯/澤瀉醇B醋酸酯/澤瀉醇B乙酸酯/澤瀉乙酸酯B/乙酸澤瀉醇B/23-乙酰澤瀉醇B/醋酸澤瀉醇B鹽/23澤瀉醇B/(1S,3R)-1-((R)-3,3-二甲氧基環(huán)氧乙烷-2-基)-3-((5R,8S,9S,10S,11S,14R)-11-羥基-4,4,8,10,14-五甲基-3-氧代-2,3,4,5,6,7,8,9,10,11,12,14,15,16-十四氫-1H-環(huán)戊基[a]菲-17-基)丁基乙酸 |
| CAS號(hào) | 26575-95-1 |
| 分子式 | C32H50O5 |
| 分子量 | 514.74 |
| 外觀 | 白色粉末 |
| 沸點(diǎn) | 590.7±50.0 °C | Condition: Press: 760 Torr |
| 酸度系數(shù)pKa | 14.74±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000711
中文名稱：澤瀉醇B-23-醋酸酯
中文別名：澤瀉醇B單醋酸酯；澤瀉醇B醋酸酯；澤瀉醇B乙酸酯；澤瀉乙酸酯B；乙酸澤瀉醇B；23-乙酰澤瀉醇B；醋酸澤瀉醇B鹽；23澤瀉醇B；(1S,3R)-1-((R)-3,3-二甲氧基環(huán)氧乙烷-2-基)-3-((5R,8S,9S,10S,11S,14R)-11-羥基-4,4,8,10,14-五甲基-3-氧代-2,3,4,5,6,7,8,9,10,11,12,14,15,16-十四氫-1H-環(huán)戊基[a]菲-17-基)丁基乙酸
英文名稱：Alisol B 23-acetate
英文別名：8α,9β,14β-Dammar-13(17)-en-3-one, 24,25-epoxy-11β,23-dihydroxy-, 23-acetate, (23S,24R)- (8CI);(8α,9β,11β,14β,23S,24R)-23-(Acetyloxy)-24,25-epoxy-11-hydroxydammar-13(17)-en-3-one;23-Acetylalismol B;23-O-Acetylalisol B;Alisol B 23-acetate;Alisol B 23-monoacetate;Alisol B monoacetate;
分子式：C32H50O5
分子量：514.74
CAS號(hào)：26575-95-1
純度：HPLC≥98%
沸點(diǎn)：590.7±50.0 °C | Condition: Press: 760 Torr
密度：1.12±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：14.74±0.70 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請(qǐng)關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Integrating Network Analysis and Metabolomics to Reveal Mechanism of Huaganjian Decoction in Treatment of Cholestatic Hepatic Injury. | ||
| 來源：SCI：Frontiers in Pharmacology | 作者：Dong Q | 備注：影響因子：5.811 |
| 引用描述 | ||
All 22 standard compounds used in this study (synephrine, gallic acid, chlorogenic acid, geniposide, peimine, peiminine, albiflorin, paeoniflorin, rutin, narirutin, crocin, naringin, hesperidin, neohesperidin, didymin, quercetin, benzoylpaeoniflorin, paeonol, sinensetin, nobiletin, hepta-3, and alisol B 23-acetate) were supplied by Weikeqi Biotechnology Co., Ltd (Chengdu, China), and the purity were all greater than 98%. UDCA administrated as positive control was supplied by Shanghai Aladdin Biochemical Co., Ltd. (Shanghai, China). ANIT and medical-grade soybean oil were purchased from Shanghai Aladdin Biochemical Co., Ltd. (Shanghai, China). | ||
